Immusoft Corporation
Total Awards:
3
Award Value:
$26,994,676
Institution type:
For profit
Short Name:
Immusoft Corporation
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Therapeutic Translational Research Projects | Dr Robert Hayes | MPS II: Plasma cell delivery of iduronate sulfatase | $3,994,676 |
| Clinical Trial Stage Projects | Dr Robert Hayes | Advancing ISP-001 for Mucopolysaccharidosis I: Clinical Expansion, Clinical Manufacturing and Release Testing | $15,000,000 |
| Clinical Trial Stage Projects | Dr Robert Hayes | A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 | $8,000,000 |
| Total: $26,994,676.00 |